ODC Life Sciences

WERE ALL ABOUT CONNECTING PATIENTS TO NOVEL THERAPIES AND CLINICAL TRIALS ODC Life Sciences acts as a partner for Biotech companies in Latin America. Our capabilities and expertise are focused on supporting global clients, from the clinical development stage throughout the entire product lifecycle. We provide services related to three main clusters: clinical trials, early access, and hosting & distribution. Our portfolio is focused on medicines for rare diseases arising from licensing (in-licensing) of developers and global registration holders of different economic groups. Mission: Provide a better life for rare disease patients and their families. Vision: Develop healthcare in Latin...

Clinical trials,orphan drugs,expanded access,patient support,rare disease,pharmaceutical,medical affairs,biotech,scientific affairs,clinical development,trial recruiting,market authorization,environmental assessment,gene therapy,small molecules,fast track designation,breakthrough therapy,and clinical research

Odc life sciences operates in the Biotechnology research industry.

Odc life sciences's revenue is 11m - 100m

Odc life sciences has 51 - 200 employees.